Erlotinib Hydrochloride Tablet, part of Loncom Pharma's Anti-cancer Drugs, is a critical component in the fight against cancer. It targets specific pathways, offering hope to cancer patients and improving their quality of life.
Shandong Loncom Pharmaceutical Co., Ltd is founded in 2012, located in Qihe Economic Development Zone, Shandong Province, with a registered capital of 60 million yuan.
